Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...
Uloženo v:
| Další autoři: | , , |
|---|---|
| Médium: | Artículo |
| Jazyk: | en_US |
| Vydáno: |
2023
|
| Témata: | |
| On-line přístup: | https://doi.org/10.2174/1389557523666230517152538 https://pubmed.ncbi.nlm.nih.gov/37198990/ |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
